TORONTO, Nov. 28, 2022 /CNW/ - Apobiologix, a division of Apotex Inc., expanded its product portfolio with the launch of a pre-filled autoinjector for Lapelga®, the company's biosimilar pegfilgrastim ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results